MassMEDIC Congratulates IGNITE Alumni Phiex Technologies on Securing the Grand Prize at This Year’s MedTech Innovator Awards
The Massachusetts Medical Device Industry Council (MassMEDIC) congratulates Medtech IGNITE Accelerator Program alumni, Phiex Technologies, on winning the grand prize at this year’s MedTech Innovator Awards during Advamed’s MedTech Conference in Boston, MA.
Boston-based Phiex Technologies’ develops self-sterilizing materials. The company seeks to create a cost-effective and environmentally safe option for manufacturers, including for the medical device industry.
CEO, CL Tian leads the company in the development of Phiex’s technology, which uses common packaging materials including plastic film or nonwoven material to sterilize devices. Phiex beat out more than 50 other startups to win the Grand Prize of $350,000.
“We are so excited for the success of CL and Phiex Technologies,” said Rachel Robinson, President of MassMEDIC’s IGNITE Accelerator Program and Chief Operating Officer of MassMEDIC. “This is just one success story within our amazing medtech ecosystem in Massachusetts and we are proud that IGNITE played a part in their journey.”
Phiex Technologies is among a stellar group of more than 55 medtech startups that have completed the IGNITE program since its relaunch in 2019. With the support of sponsors Alira Health, Boyd Technologies, Greenlight Guru, Agile Search, Wilson Sonsini, Teijin Pharma and the Massachusetts Life Sciences Center (MLSC), IGNITE offers founders mentorship from leaders of the largest medtech organizations in New England, experiential training, and investor introductions, all 100% free of charge.
“We have MassMEDIC’s IGNITE Accelerator Program to thank for putting Phiex Technologies on the map,” said CL Tian, CEO of Phiex Technologies. “Because of the incredible network and the strength of the Massachusetts medtech ecosystem, we were able to hone our business with help from mentors in leading strategics, expand our base of customers, and lay the groundwork for all the growth we've experienced this year.”
The goal of IGNITE is to attract and nurture the next generation of medtech founders and entrepreneurs, creating a pipeline of medtech startups who will help fuel the future of the Commonwealth’s medtech ecosystem by establishing offices, hiring teams, and engaging with the MassMEDIC community.
Funding raised by IGNITE companies reached over $100M this year, attracting startups from across the Commonwealth, the U.S. and globally, with a focus on inclusion and diversity among its founders, including an increasing number of female founders (75% female founders in 2022; 60% percent female founders in 2021 and 43% female founders across the last three cohorts).
In addition to Phiex Technologies’, many of the IGNITE alumni have gone on to achieve great success, including:
AOA DX, winner of three Mass Innovation Network Eddies in 2022 (Life Science award, the People’s Choice Award, and the Robert J. Crowley Award)
CoreMap, who has raised more than $33.5M in funding
RBI Medical, Phase 1 Winner of $9.8M NIH SPARC Neuromod Prize
Agile Devices, which received FDA approval for their ANGLER™ Microcatheter
Alva Health, MedTech Innovator Winner (2021 Global Competition)
Beacon Bio, acquired by Desktop Health
Envision Endoscopy, Masschallenge Platinum Boston Winner
Immad, SWSX Innovation Finalist
Kalia Health, Boston Scientific Connected Patient Challenge Winner
QSM Diagnostics, 2022 Purina Pet Care Innovation Prize
Xander, which secured a partnership with U.S. Veteran’s Affairs
For more information on IGNITE, visit www.massmedic.com/ignite.
Media Contact : Nichole Owens, email@example.com